Hindustan Bio Sciences (BOM:532041) Marketable Securities: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532041 Hindustan Bio Sciences Ltd BOM:532041
41 GF Score
Price ₹7.45
GF Value ₹3.13
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Hindustan Bio Sciences Marketable Securities?

Hindustan Bio Sciences BOM:532041 +1.36% 41 Marketable Securities is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:532041 with a GF Score™ of 41/100 and a GF Value™ of ₹3.13 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hindustan Bio Sciences's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Hindustan Bio Sciences  (BOM:532041) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hindustan Bio Sciences Marketable Securities Related Terms

Hindustan Bio Sciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for Hindustan Bio Sciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences Marketable Securities Chart

Hindustan Bio Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hindustan Bio Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:532041
41GF Score
Hindustan Bio Sciences Ltd BOM:532041
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hindustan Bio Sciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.00 Mil mean?
Hindustan Bio Sciences (BOM:532041) has a Marketable Securities of ₹0.00 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hindustan Bio Sciences and its competitors.
Is Hindustan Bio Sciences' Marketable Securities too high?
Hindustan Bio Sciences' current Marketable Securities is ₹0.00 Mil. Overall, Hindustan Bio Sciences has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' Marketable Securities compare to ZTS?
Hindustan Bio Sciences' Marketable Securities of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hindustan Bio Sciences and its competitors. Hindustan Bio Sciences's current Marketable Securities is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹3.13, compared to a current price of ₹7.45 — trading 138% above its estimated fair value. The current Marketable Securities is ₹0.00 Mil. Hindustan Bio Sciences' overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current Marketable Securities is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?

Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued. The current stock price of ₹7.45 is trading 138% above its estimated GF Value™ of ₹3.13. GuruFocus considers Hindustan Bio Sciences to be Significantly Overvalued.

Key valuation signals for BOM:532041:

  • Marketable Securities: ₹0.00 Mil
  • GF Value™: ₹3.13 vs. price of ₹7.45 (138% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hindustan Bio Sciences Business Description

Address Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
41GF Score

Get the complete analysis for BOM:532041

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.45
Price
₹3.13
GF Value